This Funding Opportunity Announcement (FOA) solicits applications for projects designed to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD)
Deadlines:
-
Letter of Intent Due Date(s): June 01, 2022
-
Application Due Date: July 01, 2022
RFA-AG-23-014 Expiration Date July 02, 2022